| INTRODUCTION
The prevalence of heart failure (HF) is increasing at the same time as treatment strategies are improving and the mean age of death from HF has risen. 1, 2 Aging of the population, worsening risk factor profile, and improved treatments and diagnostic technology have led to an increase in the prevalence of HF. [3] [4] [5] This suggests that there will be an increase in the number of patients with HF in the more advanced stages of the disease. HF is associated with high morbidity and mortality and will impose a significant economic burden on healthcare systems in the future. 6 Thus, beyond pharmacologic and other relatively expensive interventional therapies, for example, cardiac resynchronization therapy, it will be important to search for additional possible strategies to manage the symptoms of these patients. Although several established cardiovascular disease risk factors such as hypertension, diabetes, and history of coronary heart disease explain a large proportion of the risk of HF, its pathogenesis is still not fully understood, as several other factors appear to be involved. Multidisciplinary and easily applicable treatment strategies should be focused on improving the quality of life of HF patients, and therefore the value of life-style factors such as exercise training and sauna bathing among HF patients should be further investigated. 7 The access to saunas in many parts of the world, along with the relatively low cost of sauna bathing, gives it a great potential as a lifestyle treatment modality. It is therefore important to summarize the evidence and identify gaps of knowledge that can help suggest paths of future study and potential for clinical application.
The aim of this study was to assemble the evidence through a systematic review and meta-analysis of the effects of sauna bath in patients with HF, evaluated by symptoms, blood pressures, biomarkers, cardiac dimensions and function, endothelial function, and mortality.
| METHODS

| Search strategy
The search strategy was based on the PICO approach (Population, Intervention, Control, Outcome) recommended by the Cochrane Handbook for Systematic reviews. 8 We searched the databases of PubMed, 9 Cochrane library, 10 and CINAHL 11 with search terms "sauna," "saunas," "steam bath," "steam baths," and "waon therapy".
The aim was to identify all literature of the health effects of sauna bath on cardiovascular effects. The studies with cardiovascular effects were reviewed in more detail, including reference lists, to identify the studies that met the inclusion criteria. The searches were done during 2 February 2016 to 19 April 2016, with a final updated search 27 April 2017 identifying one additional study ( Figure 1 ).
| Inclusion criteria
The search results were independently reviewed by two authors (M.K. and H.H.). Studies with abstract in English were included.
Studies that met the following criteria were included in the review: (a) Randomized and nonrandomized controlled studies. 
| Assessment of study quality
The quality assessment of the randomized and nonrandomized observational studies was done using the Downs and Black checklist. 12 The last point (27) was modified to "did the study report a power calculation?" with points given as: no = 0; yes, power ≥ 70% = 1 point, ≥75% = 2 points, ≥80% = 3 points, ≥85% = 4 points and ≥ 90% = 5 points. Thus, the maximum score for quality assessment was 32. Total points by study are displayed in Table 1 . The quality of the studies was broadly divided into three categories: 0 to 10 low, 11 to 21 moderate, 22 to 32 high. This scale was not included in the original article. 12 
| Data synthesis and analysis
Studies that met the inclusion criteria and were similar in follow-up length and study design were pooled to conclude a meta-analysis. The criteria for inclusion in the meta-analysis were not prespecified and were formed after the search results. For continuous data, mean differences between the groups and SDs of the change were used and presented as random effects 95% confidence intervals (CIs) in forest plots. The data was constructed with the statistical software RevMan 5.3. 13, 14 Few of the studies that met the inclusion criteria reported the differences of the means or the SDs of the changes. In accordance with Cochrane Handbook for Systematic Reviews of Interventions, SD of the change for each outcome was calculated by using the P-values and sample sizes. In studies reporting the P-value as (P < x), the upper Statistical tests for variance were also done with the RevMan 5.3 software. 13 χ 2 statistic was used as a test for heterogeneity and I 2 statistic was used to quantify heterogeneity. Statistical heterogeneity was observed in varying degrees. As the outcomes still came basically from the same studies, all outcomes were reported with the random FIGURE 2 Forest plots of the results of the meta-analysis for the outcomes systolic blood pressure (SBP), diastolic blood pressure (DBP), left atrial diameter (LAD) and left-ventricular end-diastolic diameter (LVEDD). CI, confidence interval effects model. Narrative synthesis was used with outcomes that were found in only one study (endothelial function, mortality) and for the results that were retrieved from the studies that were not included in the meta-analysis (Basford 2009 ).
The statistical analysis was done by two authors (M.K. and L.B.).
| Quality of the evidence
To summarize the quality and strength of the evidence in support of the intervention, we used a modified version of the GRADE (The Grades of Recommendation, Assessment, Development, and Evaluation) approach. 8 The quality of evidence was rated with a scale of 4 to 1 as following: 4 = high, 3 = moderate, 2 = low, and 1 = insufficient.
The assessment was modified so that the quality of evidence of a group of studies could be reduced by: (a) Moderate risk for bias (total points 11-21, reduces by 1) and high risk for bias (total points 0-10) reduces by 2); (b) Inconsistency/heterogeneity (significant heterogeneity = I 2 ≥ 50%, reduces by 1); (c) Indirectness (if interventions of interest were directly applied to the population of interest), 15 reduces 1 if not; (d) Imprecision (mean not in favor, 95% CI not totally in favor of intervention, both reduce by 1); (e) Publication bias (reduces by 1).
| RESULTS
Of the 1444 studies, 553 studied the health effects of sauna bath. A full-text review of those studies identified 145 studies on cardiovascular effects of sauna bath. These studies were chosen as possibly eligible and checked for identification of additional records from the reference lists. A deeper review of these studies resulted in the identification of nine studies that fulfilled the inclusion criteria. A list of included studies and patient characteristics is presented in Table 1 . Of those studies, seven were included in the meta-analysis. Two studies, Kihara 2009 and Basford 2009, were excluded from the meta-analysis because of different follow-up period, outcome measure, and study design compared to the other included studies. FIGURE 3 Forest plots of the results of the meta-analysis for the outcomes B-type natriuretic peptide (BNP), left ventricular ejection fraction (EF) and cardiothoracic ratio (CTR). CI, confidence interval In the meta-analysis, the seven studies reported a total of 491 patients with HF, 275 in the sauna groups, 216 in the control groups. All the seven studies evaluated an infrared sauna therapy (Waon therapy). The frequency of sauna bath was five times a week and the follow-up periods varied from 2 to 4 weeks. The severity of HF according to the NYHA classification varied from grade II to IV at baseline, though the majority of patients (>95%) were classed II or III. The mean EF at baseline was found to be <40% in all of the studies included. As our search strategy produced a large number of records to be reviewed by full text, we have not provided a full list of excluded records.
Of the seven studies included in the meta-analysis, six were randomized. The risk for bias for each of the included studies (total points) was rated moderate by our modified version of the Downs and Black checklist.
| Risk for bias in studies included
Generally, the risk of bias in the included studies was considered moderate on a scale of 0 to 32 points, each of the studies scoring in the moderate region (11-21 total points) ( Table 1) 
NYHA class
Four studies reported NYHA classifications at baseline and at the end of the follow-up. Three of them were reported as number of patients in each class. One study reported NYHA class as means with SDs.
There were some improvements in the NYHA classifications of the patients in the sauna groups compared to the controls. No studies were included in the meta-analysis, as none of the studies reported the criteria used to judge NYHA class. The different assays for measuring BNP in the five studies are listed in Table 2 .
| Blood biomarkers
| Imaging
Left atrial and ventricular diameter
Four studies reported effects on LAD (millimeters, mm) and LVEDD −2.20 to 0.07, I 2 = 58%, P = 0.07) ( Table 3) .
EF
Six studies reported the effects of sauna bath on EF (%), which was significantly higher in patients with sauna intervention compared to controls (MD = 1.45; 95% CI: 0.55-2.35, I 2 = 0%, P = 0.002).
CTR
Six studies reported the effects on CTR (= ratio of maximal horizontal cardiac diameter to maximal horizontal thoracic diameter on x-ray).
Sauna bathing lowered the CTR significantly in comparison to control (MD = −1.82, 95% CI = −2.54 to −1.09, I 2 = 31%, P < 0.00001).
Endothelial function
One nonrandomized crossover study (Kihara 2002 
| Mortality
One study 16 
| Safety/tolerance
Two studies reported adverse events. Tei 2016 reported seven Waon therapy-related minor adverse events: decrease in blood pressure, hypovolemia, increase in urine volume, decrease in body weight, and bleeding after tooth extraction. In the Basford 2009 study no adverse events were observed.
| Quality of evidence
The quality of evidence was rated moderate to insufficient. There was moderate evidence for an effect on BNP, EF, and CTR, low evidence for outcomes SBP, DBP, and LAD, and insufficient evidence for LVEDD. The results of the assessment are presented in Table 4 . The quality of evidence varied from moderate to insufficient. The main factors that reduced the quality were risk for bias and imprecision. This means that the evidence presented by this review does support a therapeutic effect of sauna bathing on HF, and more studies are thus needed to be able to draw definitive conclusions.
| DISCUSSION
Two of the studies included observed adverse effects and reported only minor adverse effect, which might mean that sauna bath is a safe activity for this group of cardiac patients. Notably, this systematic review was not designed to assess the general safety of sauna bathing among HF patients. A possible source for identification of additional studies on safety could be inclusion of studies with other languages than English.
We could observe that no single parameter was consequently followed in all of the seven studies in the meta-analysis. Only the outcome LVEDD showed heterogeneity over the set limit (I 2 > 50%) to affect the strength of evidence. We could observe that if the Kihara 2004 study was removed, which led to reduced heterogeneity, the outcome still did not show significance. Removing Kihara 2004 from other outcomes did not change the significance of the result in any of the outcomes.
NYHA class was assessed in four of the studies included, but none of those presented the methods they used to differentiate between classes. According to previous studies, NYHA class has a high level of inter-observer variability, especially in discriminating NYHA class II and III, in which most of the patients in this review were rated. 17 Thus we refrained from separate analyses of NYHA class II and III.
A recent systematic review from Brazil only identified five studies on Waon therapy for patients with HF and showed favorable effects on natriuretic peptides and blood pressure. 18 No significant difference in blood pressure was seen in our analysis including two additional studies, instead a significant difference in EF was found. These differences in results are most likely explained by our wider search strategy resulting in 1444 compared to 247 identified studies, and 554 compared to 10 full-text reviews, respectively, in this study compared to that of the Brazilian study.
Interestingly, only Waon therapy studies were included in our study but not any other sauna bath studies including Finnish sauna bath. In 1991, Dr. Tei originally started the first pilot chronic sauna study, which is now called Waon therapy, for HF patients. 19 The sauna temperature of Waon therapy was set at 60 C which was a lower temperature than general sauna or Finnish sauna. It was given 
| Limitations
As the majority of patients had EF < 40% in all studies in the metaanalysis the results are primarily applicable for patients with HF and reduced EF. Different effects in HF patients with a preserved EF could be expected as studies have shown that these patients react differently to medical therapies and have a different pathophysiology. 21, 22 The follow-up of the studies in the meta-analysis was relatively short, with a mean duration of 2 to 4 weeks. Therefore, more studies with longer follow-up are needed to provide evidence of the longterm cardiac effects.
The studies included in the meta-analysis were interpreted to have been conducted by partly the same research groups, which must also be taken into consideration when interpreting the data.
Accurate statistical tests were not presented appropriately in every study. This might lower the accuracy of a portion of the results.
We also included both randomized and nonrandomized studies, which could be assumed to lower the scientific confidence of the results in this review. However, the only nonrandomized study did not influence the results enough to affect the quality of evidence.
As only studies with infrared sauna baths met the inclusion criteria, this review cannot show any definite supporting evidence of a positive value of Finnish sauna bathing on HF patients, although Finnish sauna might have physiological effects similar to those of an infrared sauna that operates with a lower temperature. Abbreviations: HF, heart failure; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEDD, left-ventricular end-diastolic diameter; EF, left-ventricular ejection fraction; LAD, left atrial diameter; BNP, b-type natriuretic peptide; CTR, cardiothoracic ratio.
The BNP levels were measured with different types of assays (Table 2) in the analyzed studies, and two of the studies did not report the manufacturer of the assay used. This might affect the accuracy of the BNP analysis.
| CONCLUSIONS
This study shows that infrared sauna bath was associated with short- No = 0, yes = 1, unable to determine = 0.
